z-logo
open-access-imgOpen Access
Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
Author(s) -
Dawn E. Bowles,
Scott WJ McPhee,
Chengwen Li,
Steven J. Gray,
Jade J Samulski,
Angelique S Camp,
Juan Li,
Bing Wang,
Paul E. Monahan,
Joseph E. Rabinowitz,
Joshua C. Grieger,
L. Govindasamy,
Mavis AgbandjeMcKenna,
Xiao Xiao,
R. Jude Samulski
Publication year - 2012
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/k4e8-xw30
Subject(s) - duchenne muscular dystrophy , genetic enhancement , vector (molecular biology) , muscular dystrophy , medicine , phase (matter) , gene , biology , genetics , physics , recombinant dna , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom